Ordaos

Ordaōs specializes in the development of novel therapies through the creation of mini-proteins and single domain antibodies, aimed at enhancing drug discovery for overlooked patient populations. Utilizing a generative AI-driven Design Engine, the company efficiently designs and optimizes miniPRO proteins that are smaller, more stable, and easier to... manufacture than traditional antibodies. Their innovative approach allows for rapid delivery of therapeutics, significantly reducing time to market and increasing the probability of clinical success. Ordaōs partners with pharmaceutical and biotech companies to provide tailored solutions that meet specific therapeutic needs.Read More